Total Visits

Views
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the hellenic cooperative oncology group120

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the hellenic cooperative oncology group01030011

Top country views

Views
Poland52
United States48
Sweden9
China2
France2
Greece2
Ireland2
Germany1
India1
Italy1

Top cities views

Views
Warsaw52
Louisville9
San Ramon8
Stockholm8
Boardman7
Ashburn4
San Diego3
West Chester3
Ann Arbor2
Athens2